✦ LIBER ✦

Carboplatin and Paclitaxel Plus ASA404 as First-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Multicenter Single Arm Phase II Trial (SAKK 15/08)

✍ Scribed by Martin Früh; Richard Cathomas; Marco Siano; Gregor Tscherry; Alfred Zippelius; Christoph Mamot; Andreas Erdmann; Fatima Krasniqi; Daniel Rauch; Mathew Simcock; Erika Küttel; Pierre Fustier; Miklos Pless

Book ID: 119218691
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 307 KB
Volume: 14
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2012.04.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of a 2-h infusion of gemc

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

✍ N. Xu; P. Shen; X. C. Zhang; L. F. Yu; H. Y. Bao; G. M. Shi; S. Huang; J. Chen; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 302 KB

P-778 A phase II trial of carboplatin an

P-778 A phase II trial of carboplatin and irinotecan as first-line therapy for extensive stage small cell lung cancer (ES-SCLC): Preliminary results

✍ Laskin, J.; Shirley, B.; Dobbs, T.; Bi, J.; Carbone, D.; Johnson, D.; Sandler, A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase II study of maintenance sunitinib

Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer

✍ Spigel, David R.; Greco, F. Anthony; Rubin, Mark S.; Shipley, Dianna; Thompson, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 407 KB

A phase I/randomized phase II, non-compa

A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)

✍ Roger B. Cohen; Corey J. Langer; George Rajan Simon; Peter David Eisenberg; John 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 387 KB

9147 Bevacizumab and erlotinib as first-

9147 Bevacizumab and erlotinib as first-line therapy in advanced (stage IIIB/IV) non-squamous non-small-cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression – a multicenter phase II trial of SAKK

✍ Zappa, F.; Droege, C.; Betticher, D.; von Moos, R.; Ochsenbein, A.; Stahel, R.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Bevacizumab and erlotinib (BE) first-lin

Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05)

✍ Zappa, Francesco; Droege, Cornelia; Betticher, Daniel; von Moos, Roger; Bubendor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 325 KB